Lv2
140 积分 2023-05-23 加入
Efficacy and safety of high-dose vs low-dose leucovorin in patients with colorectal cancer: systematic review and meta-analysis
23天前
已完结
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study
5个月前
已完结
Next-generation T-cell engagers for solid tumor immunotherapy
6个月前
已关闭
Emerging Claudin18.2-targeting Therapy for Systemic Treatment of Gastric Cancer: Seeking Nobility Amidst Danger
6个月前
已完结
Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma
9个月前
已完结
Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma
9个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
11个月前
已完结
The present and future of bispecific antibodies for cancer therapy
1年前
已完结
Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an antiPD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors
1年前
已完结
PD1 × VEGF blocking bispecifics for cancer draw big backing
1年前
已完结
皖公网安备34019202002308
